1Uemura N;Okamoto S;Yamamoto S.Helicobacter pylori infection and the development of gastric cancer[J],2001.
2Dixon MF.Prospects for intervention in gastric carcinogenesis:re versibility of gastric atrophy and intestinal metaplasia[J],2001.
3Campbell DI;Warren BF;Thomas JE.The African enigma:low prevalence of gastric atrophy,high prevalence of chronic inflammation in West African adults and children[J],2001(06).
4El Omar EM;Carrington M;Chow WH.Interleukin-1 polymorphisms associated with increased risk of gastric cancer[J],2000.
5Furuta T;El Omar EM;Xiao F.Interleukin 1beta polymorphisms increase risk of hypochlorhydria and atroph ic gastritis and reduce risk of duodenal ulcer recurrence in Japan[J],2002.
6Hojo M;Miwa H;Ohkusa T.Alteration of histological gas tritis after cure of Helicobacter pylori infection[J],2002.
7Sung JJ;Lin SR;Ching JY.Atrophy and intestinal metaplasia one year after cure of H pylori infection,a prospective,randomized study[J],2000(1).
8Sung JY;Lin SR;Leung WK.Does eradication of H.pylori prevent deterioration of gastric atrophy and intestinal meta plasia? A 5-year follow-up,2002.
9Correa P;Fontham ETH;Bravo JC.Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacter therapy[J],2000(23).
10Zullo A;Rinaldi V;Hassan C.Ascorbic acid and intestinal metaplasia in the stomach: a prospective, randomized study,2000.
